Infections Pneumonia

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Pneumonia Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Pneumonia Projects
--Arpida Ltd.
--Advanced Life Sciences Holdings Inc
--Bayer Ag
--Basilea Pharmaceutica AG
--Forest Laboratories Inc
--Enanta Pharmaceuticals, Inc.
--Janssen-Cilag S.p.A.
--GNI Ltd.
--Kenta Biotech Ltd.
--Johnson & Johnson
--Novartis AG
--Nektar Therapeutics
--Ortho-McNeil, Inc.
--Novexel
--Rib-X Pharmaceuticals, Inc.
--Procter & Gamble Company
--Teva Pharmaceutical Industries Ltd
--TaiGen Biotechnology Co., Ltd.
--Wyeth
--Theravance Inc

--Top Companies in early stage Pneumonia Projects
--AlphaRx Inc
--Lipoxen
--Nektar Therapeutics
--Procter & Gamble Company
--Sanofi-Aventis
--TaiGen Biotechnology Co., Ltd.
--Targanta Therapeutics Corp.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View